Apogee Enterprises (APOG) Tops Q4 EPS by 3c; Offers Guidance
Tweet
Share
E-mailGet Alerts APOG Hot Sheet
Price: $42.97 --0%
EPS Growth %: -35.7%
Financial Fact:
Operating loss: 33.05M
Today's EPS Names:
VAXX, NMRD, EGRX, More
EPS Growth %: -35.7%
Financial Fact:
Operating loss: 33.05M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Apogee Enterprises (NASDAQ: APOG) reported Q4 EPS of $0.86, $0.03 better than the analyst estimate of $0.83. Revenue for the quarter came in at $344.11 million versus the consensus estimate of $346.92 million.
GUIDANCE:
Apogee Enterprises sees FY2024 EPS of $3.90-$4.25, versus the consensus of $3.92.
For earnings history and earnings-related data on Apogee Enterprises (APOG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
